Ci Investments Inc. Mirati Therapeutics, Inc. Transaction History

Ci Investments Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $9,633 - $21,822	-246 Reduced 98.8%	3 $0
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $303 - $603	4 Added 1.63%	249 $20,000
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $6,204 - $8,943	47 Added 23.74%	245 $36,000
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $26,161 - $35,135	198 New	198 $35,000
Q1 2021 May 13, 2021	SELL	$158.92 - $221.61 $374,892 - $522,777	-2,359 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$162.05 - $240.27 $20,418 - $30,274	126 Added 5.64%	2,359 $518,000
Q3 2020 Nov 09, 2020	BUY	$113.26 - $167.27 $252,909 - $373,513	2,233 New	2,233 $371,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.